½ÃÀ庸°í¼­
»óǰÄÚµå
1660109

±¼Àý ÀÌ»ó Áúȯ ¸ðµ¨ : ±¹°¡º° Áúȯ À¯º´·ü µ¥ÀÌÅÍ(2024³â)

2024 Refractive Error Disease Model: Country-Level Disease Prevalence Data

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Scope, LLC | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±¼Àý ÀÌ»ó Áúȯ ¸ðµ¨(2024³â)Àº Àα¸ 100¸¸¸í ÀÌ»óÀÇ ¸ðµç ±¹°¡¿¡ ´ëÇØ ¿¬·ÉÃþº° 5°³ÀÇ ±¼Àý ÀÌ»ó ¹üÁÖ¿¡ ´ëÇÑ ±¹°¡ ¼öÁØÀÇ ±¤¹üÀ§ÇÑ À¯º´·ü µ¥ÀÌÅÍ¿Í 5³â°£ ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ µ¶Æ¯ÇÑ ¸ðµ¨Àº ¼¼°èÀÇ ÃֽŠÀÓ»ó ¿¬±¸¿Í Àα¸ ¿ªÇÐ ¿¹ÃøÀ» °í·ÁÇÏ¿© °í°´ÀÇ ´Ù¾çÇÑ ¿ä±¸¿¡ ¸Â°Ô Áö¿ª ¹× Áúº´ ¹üÁÖº°·Î ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Áúº´ ¸ðµ¨Àº ÀÓ»ó ¹× »ó¾÷ ´Ü°è¿¡¼­ Á¦Ç°ÀÇ Å¸°Ù ½ÃÀåÀ» Æò°¡Çϰí Áúº´ Àα¸ÀÇ ¾ç°ú Àα¸ Åë°è¿¡ ´ëÇÑ ÅëÂû·ÂÀ» ¾ò´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

³»¿ë

2024³â ±¼Àý ÀÌ»ó Áúȯ ¸ðµ¨'Àº Àα¸ 100¸¸¸í ÀÌ»óÀÇ 228 °³±¹ÀÇ ´ÙÀ½ Áúº´¿¡ ´ëÇÑ ¿¬·ÉÃþº° ±¹°¡ ¼öÁØ À¯º´·ü µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù.

  • ±Ù½Ã(ÁßÁõµµº°; Àú, Áß, °í)
  • ¿ø½Ã
  • ³ë¾È
  • ³ë¾È
  • ³­½Ã
SHW 25.03.12

Market Scope's "2024 Refractive Error Model" offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients' diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Contents:

The "2024 Refractive Error Model" provides country-level prevalence data by age group for the 228 countries with a population over a million for the following conditions:

  • Myopia (by severity; low, moderate, high)
  • Hyperopia
  • Presbyopia
  • Plano-presbyopes
  • Astigmatism
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦